| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4930831 | European Neuropsychopharmacology | 2016 | 11 Pages |
Abstract
CR may contribute to neuropsychological and functional outcome. Specific programs addressed to improve cognition and functioning conducted at the early stages of the illness may be helpful in order to prevent cognitive and functional decline.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
S. Amoretti, M. Bernardo, C.M. Bonnin, M. Bioque, B. Cabrera, G. Mezquida, B. Solé, E. Vieta, C. Torrent,